ABBOTT LABORATORIES (ABT) SEC News April 16, 2026, 11:36 UTC (99% Neutral) ABBOTT LABORATORIES (ABT) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot April 16, 2026, 11:37 a.m. 📋 ABBOTT LABORATORIES (ABT) - Financial Results Filing Date: 2026-04-16 Accepted: 2026-04-16 07:36:25 Event Type: Financial Results Event Details: ABBOTT LABORATORIES (ABT) Reports the reporting period Financial Results ABBOTT LABORATORIES (ABT) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $11,164 Net Income: 594 EPS: 0.33 Cash and equivalents: $44.32 📊 Key Financial Metrics: Metric Value Revenue $11,164 Net Income 594 Eps 0.33 Cash $44.32 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: ABBOTT LABORATORIESTicker Symbol: ABT
📋 ABBOTT LABORATORIES (ABT) - Financial Results
Filing Date: 2026-04-16
Accepted: 2026-04-16 07:36:25
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: